coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Leyland PCN, South Ribble · Health Inequalities Profile

    PCN U05906 · NHS Lancashire and South Cumbria Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    49,072

    Registered population

    58.6% aged 18–64

    22.6%

    Aged 65+

    ICB 20.0% · England 17.9%

    1.2%

    Ethnic minority (non-White)

    0.8% Asian · England 9.6%

    17.0%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    ~7,717

    Core20 residents (est.)

    Resident basis; registered basis ~8,813 · see page 3

    8,657

    Hypertension register

    +6.45% in 3 yrs · England +5.60%

    484

    SMI register

    42.7% of South Ribble's

    996

    COPD register

    Reviews -9.45% in 3 yrs

    Forecast to 2030

    10,176

    Hypertension patients, 2030

    +1,519 on today

    62.1%

    QRISK ≥20% on statins, 2030

    +2.32pp over 3 yrs

    5.8%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    57.2%
    High-risk lipid therapy and BP control lag.

    Only 57.2% of patients with QRISK ≥20% receive lipid-lowering therapy (England 63.6%) and 65.9% with hypertension meet BP targets (England 70.3%).

    1,240
    Asthma annual reviews fell over three years.

    Asthma review coverage is 64.0% (England 65.7%) after a -5.2% three-year change (England +4.4%), leaving about 1,200 register patients unreviewed.

    76.2%
    Breast and cervical screening exceed national benchmarks.

    Breast screening coverage is 76.2% (England 69.9%; +12.2% three-year change vs England +8.4%) and cervical screening aged 25-49 is 74.1% (England 66.8%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    An older population of 22.6% aged 65+ may elevate local primary care demand

    Leyland PCN encompasses 49,072 registered patients across six practices. The population is older than benchmarks: 22.6% (11,095 patients) are aged 65+, compared with 21.4% in South Ribble, 20.0% in NHS Lancashire and South Cumbria ICB, and 17.9% in England. Census usual-resident estimates in associated areas indicate a 98.8% White population (South Ribble 95.4%, ICB 87.8%, England 81.1%) and a 1.2% non-White ethnic minority share, including 0.8% Asian residents (South Ribble 2.1%, ICB 9.4%, England 9.6%). Projected list growth to 2030 is 2.1% (South Ribble 0.8%, ICB 1.7%, England 2.3%) using unverified projection methodology.

    Age profile

    0–1718.8%
    18–6458.6%
    65+22.6%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White98.8%
    Asian0.8%
    Mixed0.2%
    Black0.1%
    Other0.0%

    Older people · falls rows are South Ribble local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (South Ribble LA)1,6002,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)75.5%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.3%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (South Ribble LA)8261,0219552024/25
    Falls deaths, all ages, per 100,000 (South Ribble LA)9.218.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    A 17.0% Core20 share masks a 74.0 percentage point spread across member practices

    Leyland PCN has an average IMD decile of 6.2 (England 5.5, South Ribble 7.0) and a 17.0% Core20 share (England 21.0%, South Ribble 9.9%). Practice Core20 shares vary across a 74.0 pp range: Clayton Brook Surgery records 75.1%, whereas The Village Surgeries Croston&eccleston records 1.1%. Practice estimates sum to 8,813, against 7,717 resident-based Core20 patients. High concentration at Clayton Brook Surgery (2,461 estimated patients) contrasts with volume at Worden Medical Centre (21.9%, 3,098 estimated patients).

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Clayton Brook75.1% · 2,461 patients
    Moss Side27.9% · 1,297 patients
    Worden21.9% · 3,098 patients
    Sandy Lane11.6% · 1,212 patients
    Central Park10.7% · 632 patients
    Village Surgeries1.1% · 113 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    484

    SMI register

    0.99% recorded prevalence

    272

    Learning disability register

    0.56% recorded prevalence

    27

    Care homes, 652 beds

    In the PCN catchment

    9.5%

    Provide unpaid care

    South Ribble, Census 2021

    The PCN records 484 patients on the severe mental illness register and 272 on the learning disability register (0.6% prevalence vs England 0.6%, South Ribble 0.5%). There are 27 care homes with 652 beds in the PCN catchment, while applying the borough unpaid carer rate (9.5%) provides a ceiling estimate of about 4,700 (4,662) carers. Catchment care home beds and register sizes indicate vulnerable cohorts that may benefit from coordinated.

    Severe mental illness: physical health checks

    SMI physical health checks record blood pressure at 81.5% (England 83.4%) and BMI at 81.2% (England 82.1%). Smoking cessation support for qualifying conditions was offered to 83.9% of patients (England 94.2%), falling 12.6 pp (England +0.1 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    8,657

    Hypertension register

    +6.45%

    Register growth, 3 yrs

    South Ribble +9.36% · England +5.60%

    +0.03pp

    BP control, under 80

    ≤140/90 · −1.66pp aged 80+

    +1,519

    More patients by 2030

    Forecast 10,176 (20.02%)

    Hypertension case-finding and control

    Leyland PCN records 8,657 patients on its hypertension register (17.7%), above South Ribble (17.6%), the ICB (17.2%) and England (15.2%). However, recent blood pressure recording stands at 87.0%, below South Ribble (89.7%), the ICB (89.0%) and England (90.0%). Treatment to target reaches 65.9%, trailing South Ribble (70.9%), the ICB (70.3%) and England (70.3%), with control at 63.4% for patients aged under 80 (England 67.8%) and 76.1% for those aged 80 and over (England 81.2%). Lower treatment to target than England despite higher recorded prevalence suggests prioritising medication titration and systematic recall for uncontrolled hypertensive patients.

    Lipids and statins

    For patients with QRISK ≥20%, lipid-lowering therapy is 57.2%, trailing South Ribble (60.0%), the ICB (61.4%) and England (63.6%). Statin coverage for diabetes aged 40+ without CVD is 66.7% (England 73.2%). Fewer at-risk patients receive lipid-lowering therapy than England benchmarks, indicating a gap in primary prevention prescribing.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202684,115£1.60£1.64£1.86£134,584
    Cardiovascular (all), 2025130,990£3.63£3.38£3.33£475,494

    In 2026, the PCN prescribed 84,115 lipid-regulating drug items at £1.60 per item, below South Ribble (£1.63), the ICB (£1.64) and England (£1.86), which is £21,870 less than at England's unit cost. Lower unit costs reflect formulary choices, though unit cost does not indicate prescribing efficiency or clinical appropriateness.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −5.20%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.52%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.4% (3,447 patients; England 6.6%). Annual reviews fell 5.2% (England +4.4%) to 64.0% (England 65.7%), representing about 1,200 unreviewed patients (1,240). Asthma prescribing in ages 5-19 reached 1,717 per 1,000 (England 1,488). COPD prevalence is 2.0% (996 patients; England 1.9%), but reviews fell 9.4% (England +2.8%) to 72.8% (England 76.4%). Higher youth prescribing with falling reviews could reflect symptom management reliance, which inhaler audits could test.

    Cancer register and children's immunisation

    Cancer register prevalence is 4.8% (2,334 patients; England 3.8%). In Q1 2025/26 (cohort 136), age-5 MMR dose 1 coverage is 95.6% (England 91.7%), but dose 2 and the 4-in-1 booster both reach 86.8% (England 82.8% and 80.9%), sitting 8.2 pp below the 95.0% target with an 8.8 pp MMR dose difference.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months93.1%

    England 91.0%

    6-in-1 complete primary course at 24 months91.9%

    England 92.2%

    MMR dose 1 at 24 months90.9%

    England 88.3%

    MMR dose 2 at age 586.8%

    England 82.8%

    4-in-1 pre-school booster at age 586.8%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    Across NHS Lancashire and South Cumbria ICB in 2022, 52.4% of cancers with a known stage were diagnosed at stage 1 or 2, trailing England (55.3%) and sitting 22.6 pp below the 75.0% national ambition. Known-stage completeness was 74.6% (8,863 of 11,883 registered cancers), with about 2,010 extra early-stage cases needed annually across the ICB to reach 75%, where early diagnosis fell 1.2 pp from 2013 to 2022. PCN breast screening reaches 76.2% (England 69.9%) and cervical screening is 74.1% (England 66.8%), though Clayton Brook Surgery records 61.7%. Systemic staging shortfalls highlight wider-system delays despite strong PCN screening uptake.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Lancashire Teaching Hospitals NHS Foundation Trust achieved 82.9% on the 28-day faster diagnosis standard, exceeding the 75.0% standard, the ICB (78.4%) and England (79.3%). However, 62-day treatment was 75.0% (10.0 pp below the 85.0% standard; ICB 73.6%, England 71.2%), and 31-day treatment was 89.4% (standard 96.0%; ICB 93.6%, England 92.5%). CT diagnostic lists had 15.0% waiting 6+ weeks (England 9.9%), while MRI 6+ week waits were 2.4% (England 21.4%). Provider treatment delays and CT waiting times could lengthen cancer pathway intervals for referred patients.

    Pathways within standard (%)LancashireWrightington, Wigan and LeighEast LancashireLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)82.9082.8081.5078.3979.32
    31-day treatment (96%)89.4389.0498.1193.6292.50
    62-day referral to treatment (85%)75.0476.7873.1673.6271.16
    Diagnostic waits over 6 weeks (%)LancashireWrightington, Wigan and LeighEast LancashireEngland
    MRI2.410.490.4321.40
    CT14.977.780.159.92
    Echocardiography13.8524.370.0028.48
    Colonoscopy0.006.100.9530.83
    Gastroscopy0.0012.541.1629.02
    All 15 DM01 tests26.6514.363.2523.14
    Community services activityLancashire residentsLancashire and South Cumbria ICB
    Care contacts126,445193,720
    Referrals20,41529,855
    Patients with a contact47,32065,335

    Community services (residents of Lancashire), Jun 2026 (provisional). For South Ribble residents in June 2026, community health service activity recorded 126,445 total contacts, of which 72,000 involved adults aged 65 and over, representing a 56.9% share. High community contact volume among older residents highlights demand for coordinated post-treatment and community support.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice-level QOF achievement and phone access show marked variation across member surgeries

    In 2025/26, overall QOF achievement ranged from 92.0% at Clayton Brook Surgery to 98.1% at The Village Surgeries Croston&eccleston (England 92.5%). Vaccination and immunisation achievement spanned 46.0 pp, from 37.5% at Clayton Brook Surgery to 83.5% at The Village Surgeries Croston&eccleston (England 55.2%). Achievement points vary widely across member practices.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Worden12221.949.5%73.9%89.3%
    Village Surgeries1141.183.6%75.1%87.6%
    Sandy Lane Surgery10311.681.3%63.5%81.3%
    Central Park10510.779.7%78.9%81.1%
    Moss Side9027.955.5%83.5%75.1%
    Clayton Brook10375.171.7%65.9%74.0%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNSouth RibbleAssetPCNSouth Ribble
    Care homes (catchment)27 (652 beds)n/aSchools (catchment)50n/a
    Children's centres46Places of worship3760
    Librariesn/a3Primary schools (LA maintained)2132
    Primary academies44Special schools11

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    Asthma review coverage is 64.0% across 3,447 patients (South Ribble 66.0%, ICB 65.0%, England 65.7%), falling 5.2% from 2023 to 2025 (England +4.4%), leaving about 1,200 (1,240) unreviewed. For discussion: run structured recall using a shared review template, after-school slots, and concurrent inhaler checks. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Age-five MMR booster recall

    In Q1 2025/26 (cohort 136), age-5 MMR dose 1 is 95.6% (England 91.7%) while dose 2 is 86.8% (ICB 87.4%, England 82.8%), an 8.8 pp difference sitting 8.2 pp below the 95.0% target. For discussion: audit age-five cohorts for missing second doses and offer flexible catch-up slots alongside pre-school boosters. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 3

    Cardiovascular therapy and BP escalation

    Despite 17.7% hypertension prevalence (8,657 patients vs England 15.2%), BP control to target is 65.9% (South Ribble 70.9%, ICB 70.3%, England 70.3%) and QRISK ≥20% lipid therapy is 57.2% (England 63.6%). For discussion: deploy pharmacist-led recall for patients above blood pressure targets or with QRISK ≥20% not on lipid-lowering therapy. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Proactive older adult care planning (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Dual-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Smoking cessation support recall (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension blood pressure control audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall catch-up (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted cervical screening outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026Practice
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Age-five MMR booster recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 3 · Cardiovascular therapy and BP escalation (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15